Ophthalmic pharmaceutical company Aerie Pharmaceuticals named Michelle Senchyna, PhD, vice president of clinical development and medical affairs.
What you should know:
1. Dr. Senchyna will lead the company's clinical development and medical affairs strategy.
2. She comes to Aerie after a tenure as executive director of ophthalmology at Allergan. She previously held positions with Alcon and Panoptica and was a professor at the University of Waterloo in Canada.
3. Dr. Senchyna received restricted stock and stock options in Aerie as part of her compensation package.